Technical Analysis for EPRX - Eupraxia Pharmaceuticals Inc
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 3.630 | -1.63% | -0.060 |
Earnings due: May 9
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Hammer Candlestick | Bullish | -1.63% | |
| Pocket Pivot | Bullish Swing Setup | -1.63% | |
| New 52 Week Low | Weakness | -1.63% | |
| Outside Day | Range Expansion | -1.63% | |
| Gapped Up | Strength | -1.63% | |
| Oversold Stochastic | Weakness | -1.63% | |
| New 52 Week Closing Low | Bearish | 0.83% | |
| Stochastic Buy Signal | Bullish | 0.83% | |
| Narrow Range Bar | Range Contraction | 0.83% | |
| New 52 Week Low | Weakness | 0.83% |
| Alert | Time |
|---|---|
| Down 1% | about 2 hours ago |
| Gapped Up (Full) | 1 day ago |
| Rose Above Previous Day's High | 1 day ago |
| 10 DMA Resistance | 1 day ago |
| Up 3% | 1 day ago |
Get a Trading Sidekick!
- Earnings date: 2024-05-09
Eupraxia Pharmaceuticals Inc Description
Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidate, EP-104IAR, that is in a Phase II clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis, as well as under development for treatment of canine and equine osteoarthritis. Its products in development also include EP-201, a product candidate for prophylaxis of post-surgical infections; and EP-105, an extended-release product candidate for the local delivery of anesthetics to treat post-surgical pain. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012. Eupraxia Pharmaceuticals Inc. was founded in 2012 and is headquartered in Victoria, Canada.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Pain Life Sciences Arthritis Osteoarthritis Skeletal Disorders
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 9.1 |
| 52 Week Low | 3.44 |
| Average Volume | 75,626 |
| 200-Day Moving Average | 6.303 |
| 50-Day Moving Average | 5.280 |
| 20-Day Moving Average | 3.969 |
| 10-Day Moving Average | 3.757 |
| Average True Range | 0.313 |
| RSI (14) | 33.77 |
| ADX | 17.28 |
| +DI | 19.013 |
| -DI | 22.116 |
| Chandelier Exit (Long, 3 ATRs) | 3.853 |
| Chandelier Exit (Short, 3 ATRs) | 4.378 |
| Upper Bollinger Bands | 4.499 |
| Lower Bollinger Band | 3.439 |
| Percent B (%b) | 0.24 |
| BandWidth | 26.717 |
| MACD Line | -0.395 |
| MACD Signal Line | -0.439 |
| MACD Histogram | 0.0438 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.200 | ||||
| Resistance 3 (R3) | 4.173 | 3.977 | 4.115 | ||
| Resistance 2 (R2) | 3.977 | 3.847 | 3.990 | 4.087 | |
| Resistance 1 (R1) | 3.833 | 3.767 | 3.735 | 3.860 | 4.058 |
| Pivot Point | 3.637 | 3.637 | 3.588 | 3.650 | 3.637 |
| Support 1 (S1) | 3.493 | 3.507 | 3.395 | 3.520 | 3.322 |
| Support 2 (S2) | 3.297 | 3.427 | 3.310 | 3.293 | |
| Support 3 (S3) | 3.153 | 3.297 | 3.265 | ||
| Support 4 (S4) | 3.180 |
